ENLV
Enlivex Ltd.
NASDAQ · Healthcare · Biotechnology · IL
$0.81
+10.92%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
63.9%
Return on equity
53.1%
Return on assets
-0.8%
Return on invested capital
0.00x
Asset turnover
-$10.7M
Cash from operations
$0.34
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Dec 1, 2025